SeptRx Launches PFO Device Trial, Eyeing Mid-2012 CE-Mark Submission

Controversy remains over the clinical benefit of using a patent foramen ovale closure device to prevent strokes or other neurological events, but that has not stopped California startup SeptRx from moving ahead with early stage development of its offering.